Acrivon Therapeutics, Inc. Annual Nonoperating Income (Expense) in USD from 2021 to 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Acrivon Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2021 to 2022.
  • Acrivon Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $2.7M, a 61.5% increase year-over-year.
  • Acrivon Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $1.49M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.